SCHEMBL7185090

SCHEMBL7185090

O=C(NO)C(O)C(Nc1ccc(-c2ccccc2)cc1)C(=O)NC(Cc1ccccc1)C(=O)N1CCOCC1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 2/20 0.55
FPR2 P25090 3/20 0.46
MMP1 P03956 1/20 0.45
MMP3 P08254 1/20 0.45
CTSS P25774 2/20 0.42
MAPT P10636 1/20 0.42
REN P00797 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TACR2 P21452 1/20 0.41
CTSB P07858 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177458 0.91 MMP8 (0.52) MMP8FPR2MMP1MMP3CTSS
SCHEMBL7174696 0.87 MMP8 (0.48) MMP8CTSSRENALDH1A1TACR2
SCHEMBL7172621 0.85 MMP8 (0.46) MMP8MMP1MMP3CTSSREN
SCHEMBL7174231 0.83 MMP8 (0.45) MMP8MMP1MAPTKMT2ASMN1; SMN2
SCHEMBL7173722 0.81 FCER2 (0.57) MMP8MMP1MMP3MMP2MMP9
SCHEMBL7170637 0.80 ALOX15 (0.45) MMP8MMP1MMP3CTSSMAPT
SCHEMBL1825413 0.76 MMP8 (0.71) MMP8MMP1MMP3CTSSALDH1A1
SCHEMBL7169041 0.74 MEN1 (0.44) MMP1MMP3KMT2AMEN1MMP2
SCHEMBL7306891 0.73 ALDH1A1 (0.43) MMP8MMP1MMP3CTSSALDH1A1
SCHEMBL7173680 0.71 ALDH1A1 (0.41) MMP8CTSSALDH1A1SMN1; SMN2TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576628-B1 Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis ROCHE DIAGNOSTICS GMBH (DE) 2003-06-10 US disclosed
EP-1005449-B1 3-ARYL-SUCCINAMIDO-HYDROXAMIC ACIDS, METHODS FOR PRODUCING SAID ACIDS AND MEDICAMENTS CONTAINING THE SAME ROCHE DIAGNOSTICS GMBH (DE) 2002-10-30 EP disclosed
EP-0897908-A1 3-Aryl-succinamido-hydroxamic acids, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1999-02-24 EP disclosed